BioMed X Institute’s Post

If you need data for "Real World Evidence" (RWE) in clinical trials you should reach out to our portfolio company CliniNote or join Jan Poleszczuk for his webinar on that topic!

Attending the FP10 input conference in Oslo gathering thoughts to design the next EU research and INNOVATION framework program. More of the same!! When we struggle to demonstrate impact and create societal value, there are still calls for lower TRL projects… We need higher TRLs reached in projects! We need more results from research turned into innovation and reach the market, instead of catching dust on a shelf! We need an innovation driven FP10! More industry involvement! More societal impact! NORA – The Norwegian Artificial Intelligence Research Consortium Norges forskningsråd Innovation Norway Norwegian Smart Care Cluster Oslo Cancer Cluster Norway Health Tech Aleap The Life Science Cluster #innovation #FP10 #horizoneurope #researchinnovation

We’re honoured to receive funding from the Independent Research Fund Denmark for the projects: ‘𝙇𝙞𝙛𝙚𝙨𝙩𝙮𝙡𝙚 𝙗𝙚𝙝𝙖𝙫𝙞𝙤𝙪𝙧 𝙞𝙣 𝙢𝙞𝙙𝙡𝙞𝙛𝙚: 𝙏𝙝𝙚 𝙞𝙢𝙥𝙖𝙘𝙩 𝙤𝙣 𝙞𝙣𝙙𝙞𝙫𝙞𝙙𝙪𝙖𝙡 𝙝𝙚𝙖𝙡𝙩𝙝 𝙫𝙚𝙧𝙨𝙪𝙨 𝙨𝙤𝙘𝙞𝙚𝙩𝙖𝙡 𝙝𝙚𝙖𝙡𝙩𝙝𝙘𝙖𝙧𝙚 𝙚𝙭𝙥𝙚𝙣𝙙𝙞𝙩𝙪𝙧𝙚’ and ‘𝘿𝙚𝙛𝙞𝙣𝙞𝙣𝙜 𝙩𝙝𝙚 𝙜𝙚𝙣𝙚𝙩𝙞𝙘 𝙙𝙚𝙩𝙚𝙧𝙢𝙞𝙣𝙖𝙣𝙩𝙨 𝙤𝙛 𝙢𝙞𝙘𝙧𝙤𝙣𝙪𝙘𝙡𝙚𝙪𝙨 𝙗𝙞𝙤𝙡𝙤𝙜𝙮’. Group leader in the Diet, Cancer and Health Group at the Danish Cancer Institute, Anja viendahl Olsen, will receive funding of 2.4 million kr. for the project ‘Lifestyle behaviour in midlife’: "I'm very pleased to receive this grant. Through this new project, we will learn more about how lifestyle changes in midlife affect our health, and about how lifestyle and lifestyle changes relate to the use of healthcare services. We already know that our lifestyle affects our risk of developing cancer and other diseases, but we know less about the societal costs related to an unhealthy lifestyle. With more people needing treatment and fewer in the workforce to provide care, understanding how lifestyle factors impact our health is more crucial than ever,” Anja Olsen explains. Professor Niels Mailand will receive 2.2 million kr. for the project ‘Defining the genetic determinants of micronucleus biology’. Professor Mailand and his research group will join the Danish Cancer Institute in the new year. #cancerresearch #research #science #cancer

🌟 Such an incredible team of leading scientists on our project! 🌟 Meet the brilliant minds driving our groundbreaking research: 👨🎓 PART 1 - The Academics 🔬 Fanny Jaulin, PhD: The driving force behind our project's innovative strategies, pushing boundaries and exploring new frontiers. Research director & PI at Gustave Roussy, CEO & CSO at ORAKL 🔬Charles Baroud : A trailblazer in microfluidics, bringing expertise and insights that are reshaping the way we approach challenges. Professor at Ecole Polytechnique, Unit head at Institut Pasteur 🔬 Paul-Henry Cournède: A visionary in AI, pioneering solutions that redefine what's possible and inspire us all. Dean of Research at CentraleSupélec - Université Paris-Saclay 🔬 Michel Ducreux: A master of gastroenterology, bringing to the table his knowledge, insights on innovative therapeutic approaches. Head of the gastro-digestive committee at Gustave Roussy. 🔬 Philippe Bousso: A pioneer of immunology in the context of cancer, crafting solutions that are not just groundbreaking but also practical and impactful. Head of the Department of Immunology and the Dynamics of Immune Responses Unit at the Pasteur Institute Together, we're harnessing the power of collaboration and expertise to tackle some of the most pressing issues in precision medicine. Stay tuned for PART 2 #TeamOfScientists #Innovation #Collaboration #Science #LeadingTheWay #Research #LinkedInPost

Sometimes I like to take a few minutes to read, attend, listen to things totally outside of my "Norm" to stretch my brain and attempt to broaden my knowledge base. Just attended a Scripps Research Front Row talk "Peering into the mitochondria to reveal cellular stress and disease: Front Row lecture with Danielle Grotjahn, PhD" The mitochondria are well known for being cellular “powerhouses,” given their important role in energy generation. Yet, emerging research is now suggesting these organelles also play a key role as the stress-sensors for the cell. In this free Front Row lecture, Scripps Research assistant professor Danielle Grotjahn explored how mitochondria change shape in response to different genetic and environmental stressors. By harnessing cutting-edge imaging technologies to examine mitochondria in these never-before-seen-ways, Grotjahn is revealing how these organelles can predict overall cellular health and even disease, including neurodegenerative disorders and cancer. Was amazing to see the advances in "basic" research looking into (literally) these vital powerhouses.... ABOUT SCRIPPS RESEARCH Scripps Research is an independent, nonprofit biomedical institute based in La Jolla, California, and ranked one of the most influential in the world for its impact on innovation. The Front Row lecture series, now in its seventh season, offers an exclusive glimpse into groundbreaking scientific discoveries in action. In 2024 we celebrate a century of turning vision into pioneering impact. Reserve your seat today and learn how our scientists remain at the forefront of advancing the future of science and medicine. Each one-hour virtual lecture is free—learn more at frontrow.scripps.edu.

🌟 Empowering Heroes. Shaping the Future of Spatial Biology. 🌟 At PredxBio, we’re driven by the passion and purpose to empower cancer researchers and clinicians with the tools they need to break new ground in precision medicine. This mission came alive during our CEO, Dusty Majumdar, PhD’s stirring presentation at #SITC2024, one of the premier gatherings of thousands of experts from academia and pharma dedicated to advancing immunotherapy and cancer research. In his talk, "SpaceIQ™ – Powering Next-Generation Precision Therapeutics with AI-Driven Spatial Biomarkers," we shared how #SpatialBiology is transforming cancer research and care by unveiling the complexities of the tumor microenvironment (TME). He also guided the audience through cutting-edge use cases, demonstrating the capabilities of #SpaceIQ across cancers, including NSCLC, CRC, Breast Cancer, and DLBCL. Key insights included: 🔬 Leadership in leveraging #AI: How PredxBio is exposing the hidden circuitries of cancer through spatial biology, establishing itself as a leader in this transformative space. 💡 Broader impact: Showcasing how spatial biology and AI can advance not only #immunotherapy but also antibody-drug conjugates (#ADCs) and #multispecifics. 📊 Unmatched prediction #accuracy: PredxBio is the only solution provider achieving over 90% prediction accuracy in patient response to cancer therapies. 🧬 Network biology insights: Revealing the #NetworkBiology of cancer to answer critical questions about how and why cancer progresses and responds to treatment. The room was packed with passionate researchers, clinicians, and thought leaders, all eager to engage with the next wave of spatial intelligence. Watch entire presentation: https://lnkd.in/e9Q8MUCT With 20+ peer-reviewed publications in marquee journals, PredxBio continues to lead the way in spatial biology and precision medicine. We’re proud to celebrate Dusty’s leadership and the collective contributions of all #TheHeroesofSpatialBiology who are redefining what’s possible in cancer research and care. Together, we’re pushing boundaries, uncovering answers, and accelerating breakthroughs for patients. #CancerResearch #PrecisionMedicine #SpatialBiology #SpatialMedicine #ExplainableAI #Innovation #SITC2024 S. Chakra Chennubhotla, Craig Cinquina , Akif Burak Tosun , Filippo Pullara Brian Falkenstein , Raymond Yan , Shannon Quinn Society for Immunotherapy of Cancer (SITC), Travis J. Hollmann, MD, PhD, Michael Surace, Ph.D., Arutha Kulasinghe, Don Ariyakumar M.S , MBA, Michael Stein, Todd B., Nathan McDonald, Brianna McDonald, Juan Arango, Turan Kahraman, Jim Rulfs, Sahirzeeshan (Sahir) Ali, Burton Johnson, Hulya Koc, Ivan Strugatsky, Steve Persky, Samir Saluja, Samir Mathur Scott Davis Paul Schrimpf Daryl Travis

Check out the latest issue of #CellSignals. Here's a peek at what's inside 1️⃣ Exploratorium and Gladstone Bring a Breakthrough Science Exhibit to Life 2️⃣ Scientists Use Cancer’s Strength to Fight Against It 3️⃣ Meet Gladstone: Alicer Andrew Plus our latest publications, features in the news, and much more!

Calling all MYO7A Researchers - We want to fund your work! Save Sight Now is a patient-led organization partnered with the Foundation Fighting Blindness (FFB) to identify and fund promising Usher syndrome type 1B research. We raise approximately $400,000 annually, specifically to support research—both gene-agnostic and gene-specific—that will benefit individuals living with Usher syndrome type 1B. As a fiscally sponsored organization of FFB, our funding is restricted to MYO7A research and undergoes the same rigorous review process by their renowned Scientific Advisory Board, following the same grant cycle. This year, we are particularly interested in funding therapeutic development, but also open to other research areas. In previous years, we have focused our funding on animal and cell models, natural history studies, and research aimed at better understanding the basic biology and disease mechanisms of MYO7A. The attached image outlines the Foundation Fighting Blindness’ call for grants for their Individual Investigator Research Award, including Research Priority Areas. If you are an eligible researcher (see attached), and would like to schedule a meeting, please use this Zoom Meeting Scheduler: https://lnkd.in/ePjqEk7U OR call 800-683-5555 !!! LOI DEADLINE: October 24, 2024 !!! To learn more about the Individual Investigator Research Award, follow this link: https://lnkd.in/eN6Eb9uK #MYO7A #UsherSyndrome #GeneTherapy #RareDisease #FundingResearch #USH1B

Our latest blog, Navigating the Labyrinth: Unmasking the Hidden Pot, explores the vast potential and limitations of the arXiv API, a valuable tool for academic research. Despite its shortcomings, like the inability to filter results based on affiliation or ORCID, it offers tremendous flexibility in accessing a myriad of scholarly papers, even indirectly aiding in cancer research by connecting researchers to vital clinical trials data. The blog also discusses alternate platforms like INSPIRE-HEP and prospective upgrades, emphasizing the API's evolving role in our pursuit of knowledge in the digital age.

🚀 Exploring the Intersection of Space and Patient Health 🌌 The Center for Space Medicine Research (CSMR) was honored to play a role in highlighting the work of Catriona Jamieson, an expert from UC San Diego Sanford Stem Cell Institute, during her recent talk at Mass General Cancer Center Grand Rounds. Dr. Jamieson’s groundbreaking work on cancer "kill-switch" therapies, supported by space-based science, exemplifies the power of leveraging microgravity to advance patient health. The collaboration involves expanding our networks and “learning by sharing,” reflecting a CSMR core value of driving innovations in space for patient health here on earth. Part of our space science portfolio is about transforming insights from space research into clinical treatment and care measures that benefit people on Earth. We’re grateful for the contributions of Dr. Jamieson, Matthew Strickland, Bailey Mendel, and the entire teams at Mass General Cancer Center, UCSD Sandford, and others for pushing the boundaries of space research, medical science and patient care in necessary ways. 🌟 Read or watch more about the impactful research: 🔗https://lnkd.in/enErCgEe 🔗https://lnkd.in/errTMr_b #SpaceMedicine #CSMR #CancerResearch #PatientHealth #Innovation #StemCells The San Diego Union-Tribune